Research has demonstrated considerable heterogeneity in the longterm course of schizophrenia. In the period preceding the onset of frank psychosis (onset), patients vary relative to the rapidity of onset, the presence or absence of asociality, and the presence or absence of semipsychotic symptoms. Following the onset of psychosis (middle course), patients may suffer from episodic or unremitting psychosis, and may or may not exhibit the deficit syndrome. In late adult life (late course), patients vary relative to the presence or absence of an improvement in psychosis and social capability.
It is very likely that schizophrenia is a clinical syndrome rather than a single disease entity (Kendell 1975; McHugh and Slavney 1983; Carpenter 1987) . Clinical observation has documented the marked variation among cases in all aspects of psychopathology. Factors such as age of onset, rate of onset, early morbid or premorbid picture, symptoms and signs, interepisode residual impairments, long-term outcome, late course improvement, treatment response, and distribution of risk factors show so much difference among patients that each may prove useful as a categorical variable for the purpose of subdividing the syndrome of schizophrenia. Furthermore, many other variables (e.g., pattern of familial interaction, performance on cognitive or neuropsychological tests, biochemical assessments, and brain imaging) reveal such a range of values as to question the concept of schizophrenia as a single disease entity.
Relative homogeneity in longterm course has been the prevailing concept of schizophrenia, although it has been frequently refuted; and alternative diagnostic classes have been defined for patients with more benign course and outcome. In DSM-III and DSM-III-R (American Psychiatric Association 1980 , this approach has given way to the tautology of distinguishing putative disease entities by their duration, per se, and by an accompanying acceptance of a greatly increased heterogeneity of affective disorders; the latter include many forms of atypical psychoses and cases with mood-incongruent psychotic features. Other DSM-III and DSM-III-R psychoses, such as brief reactive psychosis, atypical psychosis, schizoaffective disorder, and schizophreniform psychosis, have doubtful validity and clinical utility.
However, even in the relatively chronic category of DSM-IH schizophrenia, considerable variability of course is observed. Angst (1988) and McGlashan (1988) document this in their reviews of European and North American followup studies, and Harding (1988) describes interesting variability observed during the course of illness. Taken together, these studies belie a single disease construct to the extent that the construct is dependent on a relatively homogeneous long-term course. Since the pathophysiology of psychoses is enigmatic, similarities in onset, symptoms, and course have been used to define disease entities. Clinical heterogeneity does not exclude the possibility of eriological homogeneity; general paresis of the insane is such an example.
This variability in clinical course is of relevance for the design of future studies. It is important to devise methods to reduce the apparent heterogeneity of schizophrenia to define the most appropriate study cohorts and to provide optimal circumstances for replication studies. Too often, when a study fails to confirm a hypothesis or replicate a previous study, it cannot be ascertained whether the failure is due to a lack of validity of the hypothesis or to an inability to construct a suitable study population for testing. In this regard, the course of schizophrenia (i.e., the nature of onset of episodes and remissions, and the nature of the illness late in its course) provides a promising criterion for reducing the heterogeneity of study populations.
As is documented in this issue, the research on the long-term course of schizophrenia leads to a number of conclusions that can be stated with confidence. This body of research also suggests important reconceptualizations of how to conduct research on schizophrenia, some of which we discuss here.
The Concept of Course of Schizophrenia
There have been several attempts to define subtypes of schizophrenia based on long-term course. Huber et al. (1975 Huber et al. ( , 1980 described 12 patterns of course of illness, while Bleuler (1968 Bleuler ( , 1978 described 7 patterns and Ciompi (1980n, 1980 ) described 8 patterns. There is extensive overlap in these descriptions, encouraging the view that a relatively small number of patterns may characterize the onset and course of illness for the vast majority of patients. In addition, Harding (1988) was able to categorize the patients in the Vermont study into the eight course patterns of Ciompi. These patterns incorporate observations about the nature of onset, the pattern of psychotic episodes, psychopathology between episodes, and the presence or absence of recovery late in the illness. There is a body of followup literature suggesting that even the progressive forms of illness tend to plateau within 5-10 years, making it feasible to classify most cases without waiting for long-term followup or ultimate outcome of illness (Bleuler 1978; Ciompi 1980 Ciompi *7, 1980b Huber et al. 1980; Engelhardt et al. 1982; Winokur 1982, 1983; Dube et al. 1984; McGlashan 1984; Achte et al. 1986 ).
Relative to reducing the heterogeneity of schizophrenia, one can delineate two approaches to using pattern of course. The first is to regard each distinctive pattern as a putative disease entity. Eight patterns are generated by the dichotomization of onset (insidious and acute), psychotic episodes (chronic or episodic), and late course pattern (deteriorated or improving) (Bleuler 1968 (Bleuler , 1978 Flekkoy et al. 1975; Huber et al. 1975 Huber et al. , 1980 Ciompi 1980a Ciompi , 1980b Harding et al. 1987«, 1987b McGlashan 1987) . This approach, depicted in figure 1 and table 1, has been useful in summarizing descriptive course data. However, the approach is difficult to implement in defining putative disease entities, because each epoch embraces multiple factors. Insidious onset may, for instance, refer to a gradually emerging psychosis or may refer to an early morbid pattern of emotional withdrawal and negative symptoms. And how is a late course patient with improving psychosis and a persevering deficit syndrome to be classified? If these psychopathological domains are to be separated, the dichotomization within each epoch of onset, middle and late course, results in four or more subgroups, not two. Rather than eight resultant patterns defining putative disease entities, two dichotomizations per epoch would result in dozens of patterns. An alternative approach is therefore more practical.
The second approach is similar but is based on a dichotomization of patients according to the particular period of clinical course, or course epoch, of interest. These three epochs are onset, middle course, and late course. Within this approach, instead of presuming that, for instance, the combination of insidious onset, prolonged psychosis, and personality deterioration defines a disease entity, one could view each of these factors as an important dichotomizing tool that may represent a lesion or disease process; one would make no a priori assumption about the relationship of each feature to those of other epochs. This approach has the practical advantage for most investigators of dividing a study cohort into two groups (e.g., acute onset vs. insidious onset of psychotic symptoms) rather than the large number of groups (see (Bleuler 1968 (Bleuler , 1978 Ciompi 1980 Ciompi *?, 1980 ; Harding et al. 1987 Harding et al. a, 1987 McGlashan 1987) . Table 2 summarizes this approach to the definition of study groups.
The Onset Epoch. There is a long tradition of dividing the schizophrenic syndrome according to premorbid, early morbid, and onset characteristics. The dichotomies of good versus poor premorbid, reactive versus process schizophrenia, and acute versus insidious onset are examples of putative entities defined by the features of the epoch of onset. These dichotomies have been validated by assessing shortand long-term outcome, association with precipitating stressors, prediction of treatment response, prediction of familial distribution of schizophrenia spectrum cases, and, with less consistency, age of onset, psychophysiological and biochemical markers, and structural alterations in the brain (Vaillant 1962; Stephens 1978; Strauss and Carpenter 1979; Shelton and Weinberger 1986; Andreasen 1987) . Within this epoch, it is important to choose with care the aspect of psychopathology used to define cohorts. Some workers have focused on the rate of evolving psychosis (i.e., acute vs insidious), while others have viewed impairment in personality development as critical (e.g., asocial vs. social, process vs. reactive). Predictive power is no doubt enhanced by combining features of both psychotic and nonpsychotic features, and clinicians routinely base prognosis on data from developmental history and onset of psychosis. However, for purposes of reducing heterogeneity to study specific psychopathological processes, it is useful and probably valid to consider personality pathology separately from psychosis and its rate of onset (Kety et al. 1968; Kendler et al. 1986; Gottesman et al. 1987 ).
The Epoch of Middle Course. All currently accepted diagnostic criteria for schizophrenia include positive symptoms of psychosis (e.g., hallucinations and delusions); the course of this psychosis is quite variable. Terms in the literature such as "chronic," "treatmentrefractory," "residual symptoms," and "poor functioning" usually fail to make clear the extent to which the relevant dichotomization is based on interepisode personality pathology or on the persistence of psychosis per se. At our present state of knowledge, it is important to allow for the possibility that factors involved in the pathogenesis of psychotic symptoms (hallucinations, delusions, and marked formal thought disorder) may be different from factors involved in the pathogenesis of longstanding interepisode impairments of personality. Family aggregation studies confirm this view (Heston 1966; Kendler et al. 1986 ).
The Late Course Epoch. Those who have viewed schizophrenia as a chronic, deteriorating illness have sometimes proposed long-term outcome as a definitive diagnostic and dichotomizing tool. Recovery or very substantial improvement disallowed the diagnosis of schizophrenia, and diagnoses such as schizophreniform psychosis were introduced for the nonprogressive cases (Kleist 1960; Leonhard 1966; Langfeldt 1969) .
Work from around the world has now documented variability in course, regardless of diagnostic criteria (Bleuler 1968 (Bleuler , 1978 Flekkoy et al. 1975; Hawk et al. 1975; Brockington et al. 1978; Kendell et al. 1979; Ciompi 1980fl, 1980b Angst 1988; Harding 1988; McGlashan 1988) . A substantial number of patients with schizophrenia show sustained and substantial improvement in psychopathology late in the course of illness, the proportion of such cases depending on diagnostic criteria and perhaps on treatment and cultural/environmental circumstances as well (Lin and Kleinman 1988) . This improvement can apparently involve decreased intensity of psychosis or improvement in nonpsychotic impairments. Predictors of late course improvement have not yet been well validated, but McGlashan (1987) examined 100 clinical and demographic variables from patients' distant past and found only five variables predictive of late improvement at the p = .05 level. All five may be chance findings, but family closeness (/) = 0.1) and schizotypal personality (p = .02) merit further study.
Some conceptual distinctions will assist in the investigation of late course processes: (1) We suggest that study groups should be differentiated according to whether improvements occur in psychotic or nonpsychotic aspects of illness, or both. (2) Of those patients with the deficit syndrome (one form of nonpsychotic impairment), it may prove very interesting to differentiate between early onset (i.e., early deficit morbidity before psychosis) cases and those cases in which the deficit syndrome developed only after the appearance of psychosis.
Using Epochs for Research: The Domains Approach
We have argued elsewhere that schizophrenia is a clinical syndrome defined by combining quite divergent aspects of psychopathology (Carpenter et al. 1985) . In the absence of valid disease entities, it is useful conceptually to identify domains of psychopathology, such as positive symptoms or the deficit syndrome, for independent scrutiny (Carpenter and Buchanan, in press). Course patterns may also depend on distinct pathophysiological processes and, thus, are also candidates for this approach. For each epoch, we give below an example of a hypothesis relating to a dichotomy within that epoch.
Concerning the first epoch (onset), there is evidence that chronic schizophrenia is genetically linked to the schizophrenia spectrum and that acute schizophrenia is not (Kety et al. 1968 ). The clinical features that define chronicity have not been teased apart, so the basis for the excess of the schizophrenia spectrum in biological relatives of chronic schizophrenic probands is not known. Defining cohorts using first epoch patterns may clarify this important issue. One could replicate the finding that a high prevalence of schizophrenia spectrum relatives is associated with childhood asociality in schizophrenic probands (Kendler et al. 1982) by subdividing a cohort of schizophrenic probands according to the presence or absence of this feature and determining the prevalence of the schizophrenia spectrum among biological relatives of the two schizophrenic cohorts (and appropriate controls). Such a design would be strengthened if the two proband cohorts were similar in rate of onset of psychosis and the features of the other epochs, thus increasing the likelihood that a nonpsychotic childhood impairment would be the crucial variable.
Concerning the second epoch (middle course), a question of prime importance is the pathophysiological mechanism that underlies persistent as opposed to remitting psychosis. To help isolate this factor in a study design, patients with schizophrenia could be dichotomously categorized on the basis of persistent and remitting psychoses. To avoid a confounding effect, the two study cohorts must be similar relative to the features of the first epoch. We would hypothesize that the pathophysiological difference in these two patterns of psychosis is based on a failure of a homeostatic mechanism in mesocortical or mesolimbic dopaminergic systems in patients with persistent psychosis. Studying the responses of various dopaminergic systems to pharmacologic probes, using variables such as prolactin, homovanillic acid, and in vivo dopamine receptor imaging, could be informative if the comparative cohorts were similar in onset and psychotic state at time of study but differed relative to persistence or remission of psychosis. Again, more specific conclusions can be achieved by shifting from the acute/chronic dichotomy to a discrete pattern of pathology within a specified epoch.
Concerning the third epoch (late course), it will be important to discover the mechanisms that lead to late improvement in a subgroup of patients. Here one might hypothesize that an amelioration of psychosis is associated with an agerelated decrease in the number of neurons in dopaminergic systems, and that patients vary considerably in the age of occurrence and in the rate and extent of these neuronal changes. Using variables that permit inferences about this neuronal mechanism hypothesis, the investigator would define cohorts distinguished by late improvement versus nonimprovement in psychosis, but which are otherwise comparable.
Discussion
Certain assumptions underlie the epoch-based research strategy outlined above: (1) there are a variety of psychopathological domains within schizophrenia; (2) these domains differ in their pathophysiology and associated risk factors; and (3) these pathological processes can occur independently and can be observed in attenuated form (e.g., schizoid traits and subtle thought disorder). Although an underlying biological heterogeneity of schizophrenia is not unequivocally established, it is certainly heuristic to hypothesize etiological and pathogenetic heterogeneity (Carpenter and Buchanan, in press). If schizophrenic patients suffer from diverse pathophysiological processes, studying heterogeneous groups will obscure these processes, whereas if there is a unitary pathophysiology underlying schizophrenia, studying more homogeneous subgroups will not undermine the elucidation of that single process.
Dichotomizing study populations on the basis of individual epochs as described here has important advantages relative to the "disease entity" approach which was summarized earlier. There is first the practical advantage that the researcher needs only to contrast two groups, rather than to define a number of putative disease entities. If the psychopathological domains model is a valid one, then there is another important advantage having to do with the interpretation of study results. For instance, suppose a biological marker distinguished classic "process" schizophrenic patients (with an insidious onset and unremitting psychotic symptoms) from classic "good prognosis" patients (with an acute onset and an episodic course of psychotic symptoms). It would be difficult to interpret such a finding, as the marker could be associated with the prepsychotic abnormality or with the pattern of course of the psychotic symptoms. However, if the two study groups differed in the nature of their onset but not relative to the course of their psychotic symptoms, a correlation with a marker would have a more specific interpretation. The latter design would be clearly mandated by the epochs approach.
There is already extensive evidence supporting the value of subdividing the schizophrenia syndrome by course pattern or domain of pathology. Distinctions such as acute/chronic, Kraepelinian/nonKraepelinian, or type 1/ 11 have already been productive (Kety et al. 1968; Crow 1985; Losonczy et al. 1986 ). The power of such dichotomies will be increased by explicit attention to the domain of pathology and phase of illness upon which the subtypes are being delineated. Long-term followup studies provide a strong basis for examining these three epochs, and Harding (1988) and McGlashan (personal communication) have demonstrated an ability to apply similar criteria to new study cohorts This conceptual approach may guide the investigator in several crucial tasks:
• The elucidation of the many pathological processes which, in various combinations, lead to the heterogeneous clinical syndromes which currently define schizophrenia.
• The clarification of those pathological processes which are shared across nosological classes and those which are specific to schizophrenia.
• The identification of areas neglected by previous research (e.g., neuroleptic effects in the third epoch).
It is to be anticipated that new data generated within this conceptual framework will provide the scientific basis for advances in nosology of relevance to DSM-IV and ICD-10. Application of the course typology in psychosis other than schizophrenia may even provide a basis for a new division of the psychoses. For instance, almost 20 percent of major affective disorder patients have a chronic course (Rennie 1942; Keller and Shapiro 1982; Keller et al. 1983 ). Do many of these patients have insidious onset or late course deficits? If so, does this subgroup share a pathophysiological process with some chronic schizophrenic patients? A focus on epochs may clarify whether similar causal mechanisms are involved in discrete aspects of several entities we now consider independent diseases.
